Critical assessment of how to study addiction and its treatment: Human and non-human animal models

Pharmacology & Therapeutics - Tập 108 - Trang 18-58 - 2005
Charles P. O'Brien1, Eliot L. Gardner2
1Department of Psychiatry, University of Pennsylvania School of Medicine, and Philadelphia, VA Medical Center, Mental Illness Research and Education Center, 3900 Chestnut Street, Philadelphia, PA, 19104, USA
2Neuropsychopharmacology Section, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, U.S. Department of Health and Human Services, 5500 Nathan Shock Drive, Baltimore, MD 21224, USA

Tài liệu tham khảo

Abrahamsen, 1995, Curve-shift analysis of self-stimulation in food-restricted rats: relationship between daily meal, plasma corticosterone and reward sensitization, Brain Res, 695, 186, 10.1016/0006-8993(95)00764-H Acheson, 2000, Lesions and inactivation implicate dorsomedial hindbrain in MFB self-stimulation, Physiol Behav, 71, 159, 10.1016/S0031-9384(00)00325-5 Adams, 1976, Probing brain chemistry with electroanalytical techniques, Anal Chem, 48, 1126A, 10.1021/ac50008a001 Adams, 1978, In vivo electrochemical recording: a new neurophysiological technique, Trends Neurosci, 1, 160, 10.1016/0166-2236(78)90098-X Addolorato, 2000, Ability of baclofen in reducing alcohol craving and intake: II. Preliminary clinical evidence, Alcohol Clin Exp Res, 24, 67 Addolorato, 2002, Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study, Alcohol Alcohol, 37, 504, 10.1093/alcalc/37.5.504 Allan, 1998, The relationship between negative symptoms of schizophrenia and extrapyramidal side effects with haloperidol and olanzapine, Psychopharmacol Bull, 34, 71 Altshuler, 1980, Alternation of ethanol self-administration by naltrexone, Life Sci, 26, 679, 10.1016/0024-3205(80)90257-X Ameisen, 2005, Complete and prolonged suppression of symptoms and consequences of alcohol-dependence using high-dose baclofen: a self-case report of a physician, Alcohol Alcohol, 40, 147, 10.1093/alcalc/agh130 American Psychiatric Association, 2000 Andreoli, 2003, Selective antagonism at dopamine D3 receptors prevents nicotine-triggered relapse to nicotine-seeking behavior, Neuropsychopharmacology, 28, 1272, 10.1038/sj.npp.1300183 Andreoli, 2003, Effect of selective antagonism of dopamine D3 receptor by SB-277011-A on oral alcohol self-administration in mice, Eur Neuropsychopharmacol, 13, S17, 10.1016/S0924-977X(03)90011-3 Annau, 1974, Electrical self-stimulation of single and multiple loci: long term observations, Physiol Behav, 13, 281, 10.1016/0031-9384(74)90046-8 Anthony, 1994, Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: basic findings from the National Comorbidity Survey, Exp Clin Psychopharmacol, 2, 244, 10.1037/1064-1297.2.3.244 Arnold, 1997, A critique of fixed ratio and progressive ratio schedules used to examine the neural substrates of drug reinforcement, Pharmacol Biochem Behav, 57, 441, 10.1016/S0091-3057(96)00445-5 Ashby, 1999, Implication of the GABAB receptor in gamma vinyl-GABA's inhibition of cocaine-induced increases in nucleus accumbens dopamine, Synapse, 31, 151, 10.1002/(SICI)1098-2396(199902)31:2<151::AID-SYN8>3.0.CO;2-W Ashby, 2002, Systemic administration of 1R,4S-4-amino-cyclopent-2-ene-carboxylic acid, a reversible inhibitor of GABA transaminase, blocks expression of conditioned place preference to cocaine and nicotine in rats, Synapse, 44, 61, 10.1002/syn.10052 Ashby, 2003, Acute administration of the selective D3 receptor antagonist SB-277011-A blocks the acquisition and expression of the conditioned place preference response to heroin in male rats, Synapse, 48, 154, 10.1002/syn.10188 Assadi, 2003, Baclofen for maintenance treatment of opioid dependence: a randomized double-blind placebo-controlled clinical trial [ISRCTN32121581], BMC Psychiatry, 18, 16, 10.1186/1471-244X-3-16 Awad, 1993, Subjective response to neuroleptics in schizophrenia, Schizophr Bull, 19, 609, 10.1093/schbul/19.3.609 Baker, 1998, Effects of intraaccumbens administration of SCH-23390 on cocaine-induced locomotion and condition place preference, Synapse, 30, 181, 10.1002/(SICI)1098-2396(199810)30:2<181::AID-SYN8>3.0.CO;2-8 Bardo, 1998, Neuropharmacological mechanisms of drug reward: beyond dopamine in the nucleus accumbens, Crit Rev Neurobiol, 12, 37, 10.1615/CritRevNeurobiol.v12.i1-2.30 Bartoletti, 2004, The GABAB agonist baclofen blocks the expression of sensitisation to the locomotor stimulant effect of amphetamine, Behav Pharmacol, 15, 397, 10.1097/00008877-200409000-00014 Baseski, 2005, Capillary liquid chromatography with MS3 for the determination of enkephalins in microdialysis samples from the striatum of anesthetized and freely-moving rats, J Mass Spectrom, 40, 146, 10.1002/jms.733 Bauco, 2001, Effects of neurotensin receptor inactivation on brain stimulation reward in Fischer 344 and Lewis rats, Eur J Pharmacol, 432, 57, 10.1016/S0014-2999(01)01466-2 Beal, 2001, Experimental models of Parkinson's disease, Nat Rev Neurosci, 2, 325, 10.1038/35072550 Belmaker, 1977, Haloperidol in normals, Br J Psychiatry, 131, 222, 10.1192/bjp.131.2.222b Benveniste, 1989, Brain microdialysis, J Neurochem, 52, 1667, 10.1111/j.1471-4159.1989.tb07243.x Betarbet, 2002, Animal models of Parkinson's disease, Bioessays, 24, 308, 10.1002/bies.10067 Bindra, 1968, Neuropsychological interpretation of the effects of drive and incentive-motivation on general activity and instrumental behavior, Psychol Rev, 75, 1, 10.1037/h0025306 Blum, 2001, Molecular pathways involved in the neurotaxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease, Prog Neurobiol, 65, 135, 10.1016/S0301-0082(01)00003-X Bolam, 1995, Microcircuitry of the neostriatum, 1 Bourne, 2003, Intracerebral microdialysis: 30 years as a tool for the neuroscientist, Clin Exp Pharmacol Physiol, 30, 16, 10.1046/j.1440-1681.2003.03789.x Bouthenet, 1991, Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA, Brain Res, 564, 203, 10.1016/0006-8993(91)91456-B Bozarth, 1983, Opiate reward mechanisms mapped by intracranial self-administration, 331 1987 Bozarth, 1987, Intracranial self-administration procedures for the assessment of drug reinforcement, 173 Bozarth, 1981, Heroin reward is dependent on a dopaminergic substrate, Life Sci, 29, 1881, 10.1016/0024-3205(81)90519-1 Bozarth, 1984, Anatomically distinct opiate receptor fields mediate reward and physical dependence, Science, 224, 516, 10.1126/science.6324347 Brady, 1984, Testing Drugs for Physical Dependence Potential and Abuse Liability, vol. 52 Brebner, 1999, The GABAB agonist CGP 44532 decreases cocaine self-administration in rats: demonstration using a progressive ratio and a discrete trials procedure, Neuropharmacology, 38, 1797, 10.1016/S0028-3908(99)00094-5 Brebner, 2000, Intra-VTA baclofen attenuates cocaine self-administration on a progressive raio schedule of reinforcement, Pharmacol Biochem Behav, 66, 857, 10.1016/S0091-3057(00)00286-0 Brebner, 2000, Effects of baclofen on cocaine self-administration in rats reinforced under fixed-ratio 1 and progressive-ratio schedules, Psychopharmacology, 148, 314, 10.1007/s002130050056 Brebner, 2002, The GABAB antagonist CGP56433A attenuates the effect of baclofen on cocaine but not heroin self-administration in the rat, Psychopharmacology, 160, 49, 10.1007/s00213-001-0952-7 Brebner, 2002, A potential role for GABAB agonists in the treatment of psychostimulant addiction, Alcohol Alcohol, 37, 478, 10.1093/alcalc/37.5.478 Brebner, 2005, Attenuation of d-amphetamine self-administration by baclofen in the rat: behavioral and neurochemical correlates, Psychopharmacology, 177, 409, 10.1007/s00213-004-1968-6 Breiter, 1999, Functional magnetic resonance imaging of brain reward circuitry in the human, Ann N Y Acad Sci, 877, 523, 10.1111/j.1749-6632.1999.tb09287.x Bressan, 2000, Striatal D2 blockade and depression in schizophrenia—SPET findings, Biol Psychiatry, 47, 128S, 10.1016/S0006-3223(00)00689-2 Bressan, 2002, Typical antipsychotic drugs—D2 receptor occupancy and depressive symptoms in schizophrenia, Schizophr Res, 56, 31, 10.1016/S0920-9964(01)00185-2 Broadbent, 1999, Differential effects of GABAA and GABAB agonists on sensitization to the locomotor stimulant effects of ethanol in BDA/2 J mice, Psychopharmacology, 141, 197, 10.1007/s002130050825 Brodie, 2003, Treating cocaine addiction: from preclinical to clinical trial experience with γ-vinyl GABA, Synapse, 50, 261, 10.1002/syn.10278 Brodie, 2005, Safety and efficacy of γ-vinyl GABA (GVG) for the treatment of methamphetamine and/or cocaine addiction, Synapse, 55, 122, 10.1002/syn.20097 Buckett, 1981, The influence of a GABA transaminase inhibitor, γ-vinyl-GABA, on voluntary morphine consumption in the rat, Psychopharmacology, 75, 214, 10.1007/BF00432191 Buczek, 1999, Stress reinstates nicotine seeking but not sucrose solution seeking in rats, Psychopharmacology, 144, 183, 10.1007/s002130050992 Caine, 1993, Modulation of cocaine self-administration in the rat through D-3 dopamine receptors, Science, 260, 1814, 10.1126/science.8099761 Campbell, 1985, A microcomputer-based method for physiologically-interpretable measurement of the rewarding efficacy of brain stimulation, Physiol Behav, 35, 395, 10.1016/0031-9384(85)90315-4 Campbell, 1999, Effects of baclofen on maintenance and reinstatement of intravenous cocaine self-administration in rats, Psychopharmacology, 143, 209, 10.1007/s002130050937 Campos, 2003, The dopamine D3 receptor antagonist SB277011A antagonizes nicotine enhanced brain-stimulation reward in rat Campos, 2004, Blockade of dopamine D3 receptors by SB-277011A, NGB 2904 or BP 897 attenuates nicotine-enhanced brain stimulation reward in rat Capriles, 2003, A role for the prefrontal cortex in stress- and cocaine-induced reinstatement of cocaine seeking in rats, Psychopharmacology, 168, 66, 10.1007/s00213-002-1283-z Carlezon, 1996, Rewarding actions of phencyclidine and related drugs in nucleus accumbens shell and frontal cortex, J Neurosci, 16, 3112, 10.1523/JNEUROSCI.16-09-03112.1996 Carr, 2002, Augmentation of drug reward by chronic food restriction: behavioral evidence and underlying mechanisms, Physiol Behav, 76, 353, 10.1016/S0031-9384(02)00759-X Chang, 1994, Electrophysiological and pharmacological evidence for the role of the nucleus accumbens in cocaine self-administration in freely moving rats, J Neurosci, 14, 1224, 10.1523/JNEUROSCI.14-03-01224.1994 Chen, 1996, Systemic cocaine challenge after chronic cocaine treatment reveals sensitization of extracellular dopamine levels in nucleus accumbens but direct cocaine perfusion into nucleus accumbens does not: implications for the neural locus of cocaine sensitization, Life Sci [Pharmacol Lett], 14, P139, 10.1016/S0024-3205(96)80014-2 Chester, 2002, GABAA receptor modulation of the rewarding and aversive effects of ethanol, Alcohol, 26, 131, 10.1016/S0741-8329(02)00199-4 Childress, 1999, Limbic activation during cue-induced cocaine craving, Am J Psychiatry, 156, 11, 10.1176/ajp.156.1.11 Christie, 1987, Excitatory amino acid projections to the nucleus accumbens septi in the rat: a retrograde transport study utilizing D[3H]aspartate and [3H]GABA, Neuroscience, 22, 425, 10.1016/0306-4522(87)90345-9 Chrobak, 1993, Opioid and GABA modulation of accumbens-evoked ventral pallidal activity, J Neural Transm Gen Sect, 93, 123, 10.1007/BF01245342 Church, 1987, Detecting behaviorally relevant changes in extracellular dopamine with microdialysis, Brain Res, 412, 397, 10.1016/0006-8993(87)91150-4 Colombo, 2002, The GABAB receptor agonists baclofen and CGP 44532 prevent acquisition of alcohol drinking behaviour in alcohol-preferring rats, Alcohol Alcohol, 37, 499, 10.1093/alcalc/37.5.499 Colombo, 2004, Role of GABAB receptor in alcohol dependence: reducing effect of baclofen on alcohol intake and alcohol motivational properties in rats and amelioration of alcohol withdrawal syndrome and alcohol craving in human alcoholics, Neurotox Res, 6, 403, 10.1007/BF03033315 Comer, 2002, Intravenous buprenorphine self-administration by detoxified heroin abusers, J Pharmacol Exp Ther, 301, 266, 10.1124/jpet.301.1.266 Comer, 2002, Depot naltrexone: long-lasting antagonism of the effects of heroin in humans, Psychopharmacology, 159, 351, 10.1007/s002130100909 Corbett, 1980, Intracranial self-stimulation in relation to the ascending dopaminergic systems of the midbrain: a moveable electrode mapping study, Brain Res, 185, 1, 10.1016/0006-8993(80)90666-6 Cornish, 2000, Glutamate transmission in the nucleus accumbens mediates relapse in cocaine addiction, J Neurosci, 20, RC89, 10.1523/JNEUROSCI.20-15-j0006.2000 Cornish, 2001, Cocaine sensitization and craving: differing roles for dopamine and glutamate in the nucleus accumbens, J Addict Dis, 20, 43, 10.1300/J069v20n03_05 Cornish, 1997, Naltrexone pharmacotherapy for opioid dependent federal probationers, J Subst Abuse Treat, 14, 529, 10.1016/S0740-5472(97)00020-2 Corrigall, 2000, Response of nicotine self-administration in the rat to manipulations of μ-opioid and γ-aminobutyric acid receptors in the ventral tegmental area, Psychopharmacology, 149, 107, 10.1007/s002139900355 Corrigall, 2001, GABA mechanisms in the pedunculopontine tegmental nucleus influence particular aspects of nicotine self-administration selectively in the rat, Psychopharmacology, 158, 190, 10.1007/s002130100869 Coulombe, 1987, Fitting intracranial self-stimulation data with growth models, Behav Neurosci, 101, 209, 10.1037/0735-7044.101.2.209 Cousins, 2002, GABAB receptor agonists for the treatment of drug addiction: a review of recent findings, Drug Alcohol Depend, 65, 209, 10.1016/S0376-8716(01)00163-6 Craig, 1985, Measurement of mood and affect in schizophrenic patients, Am J Psychiatry, 142, 1272, 10.1176/ajp.142.11.1272 Dackis, 2001, Cocaine dependence: a disease of the brain's reward centers, J Subst Abuse Treat, 21, 111, 10.1016/S0740-5472(01)00192-1 Dackis, 2003, Modafinil and cocaine: a double-blind, placebo-controlled drug interaction study, Drug Alcohol Depend, 70, 29, 10.1016/S0376-8716(02)00335-6 Davies, 2000, Analytical considerations for microdialysis sampling, Adv Drug Deliv Rev, 45, 169, 10.1016/S0169-409X(00)00114-9 Davis, 1974, Naloxone use to eliminate opiate-seeking behavior: need for extinction of conditioned reinforcement, Biological Psychiatry, 9, 181 de Haan, 2000, Subjective experience and striatal dopamine D2 receptor occupancy in patients with schizophrenia stabilized by olanzapine or risperidone, Am J Psychiatry, 157, 1019, 10.1176/appi.ajp.157.6.1019 de Haan, 2004, Subjective experience and dopamine D2 receptor occupancy in patients treated with antipsychotics: clinical implications, Can J Psychiatry, 49, 290, 10.1177/070674370404900503 Delgado, 1970, Telecommunication in brain research, vol. 5, 270 Delgado, 1972, Dialytrode for long term intracerebral perfusion in awake monkeys, Arch Int Pharmacodyn Ther, 198, 9 De Vries, 1999, Dopaminergic mechanisms mediating the incentive to seek cocaine and heroin following long-term withdrawal of IV drug self-administration, Psychopharmacology, 143, 254, 10.1007/s002130050944 Dewey, 1997, GABAergic attenuation of cocaine-induced dopamine release and locomotor activity, Synapse, 25, 393, 10.1002/(SICI)1098-2396(199704)25:4<393::AID-SYN11>3.0.CO;2-W Dewey, 1998, A novel strategy for the treatment of cocaine addiction, Synapse, 30, 119, 10.1002/(SICI)1098-2396(199810)30:2<119::AID-SYN1>3.0.CO;2-F Dewey, 1999, A pharmacologic strategy for the treatment of nicotine addiction, Synapse, 31, 76, 10.1002/(SICI)1098-2396(199901)31:1<76::AID-SYN10>3.0.CO;2-Y de Wit, 1981, Reinstatement of cocaine-reinforced responding in the rat, Psychopharmacology, 75, 134, 10.1007/BF00432175 de Wit, 1977, Blockade of cocaine reinforcement in rats with the dopamine receptor blocker pimozide, but not with the noradrenergic blockers phentolamine or phenoxybenzamine, Can J Psychol, 31, 195, 10.1037/h0081662 deWit, 1989, Reinforcing and subjective effects of diazepam in non-drug abusing volunteers, Pharmacol Biochem Behav, 33, 205, 10.1016/0091-3057(89)90451-6 Di Chiara, 1998, A motivational learning hypothesis of the role of mesolimbic dopamine in compulsive drug use, J Psychopharmacol, 12, 54, 10.1177/026988119801200108 Di Chiara, 1999, Drug addiction as dopamine-dependent associative learning disorder, Eur J Pharmacol, 375, 13, 10.1016/S0014-2999(99)00372-6 Di Chiara, 1988, Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats, Proc Natl Acad Sci U S A, 85, 5274, 10.1073/pnas.85.14.5274 Di Ciano, 2003, The GABAB receptor agonist baclofen attenuates cocaine- and heroin-seeking behavior by rats, Neuropsychopharmacology, 28, 510, 10.1038/sj.npp.1300088 Di Ciano, 2003, Attenuation of cue-controlled cocaine-seeking by a selective D3 dopamine receptor antagonist SB-277011-A, Neuropsychopharmacology, 28, 329, 10.1038/sj.npp.1300148 Diaz, 2000, Dopamine D3 receptors expressed by all mesencephalic dopamine neurons, J Neurosci, 20, 8677, 10.1523/JNEUROSCI.20-23-08677.2000 Dixon, 1991, Drug abuse in schizophrenic patients: clinical correlates and reasons for use, Am J Psychiatry, 148, 224, 10.1176/ajp.148.2.224 Dobrovitsky, 2002, CGP 44532, a GABAB receptor agonist, is hedonically neutral and reduces cocaine-induced enhancement of reward, Neuropharmacology, 42, 626, 10.1016/S0028-3908(02)00007-2 Ehrman, 1992, Conditioned tolerance in human opiate addicts, Psychopharmacology (Berl), 108, 218, 10.1007/BF02245311 Emerich, 1991, Neuroleptic dysphoria, Biol Psychiatry, 29, 201, 10.1016/0006-3223(91)91281-U Erb, 1996, Stress reinstates cocaine-seeking behavior after prolonged extinction and drug-free periods, Psychopharmacology, 128, 408, 10.1007/s002130050150 Erb, 1998, The role of corticotropin-releasing factor and corticosterone in stress- and cocaine-induced relapse to cocaine seeking in rats, J Neurosci, 18, 5529, 10.1523/JNEUROSCI.18-14-05529.1998 Erb, 2000, Alpha-2 adrenergic receptor agonists block stress-induced reinstatement of cocaine-seeking, Neuropsychopharmacology, 23, 138, 10.1016/S0893-133X(99)00158-X Esposito, 1987, Brain stimulation reward: measurement and mapping by psychophysical techniques and quantitative 2-[14C]deoxyglucose autoradiography, 421 Ettenberg, 1982, Heroin and cocaine intravenous self-administration in rats: mediation by separate neural systems, Psychopharmacologia, 78, 204, 10.1007/BF00428151 Everitt, 2001, Second order schedules of drug reinforcement in rats and monkeys: measurement of reinforcing efficacy and drug-seeking basis behaviour, Psychopharmacology, 153, 17, 10.1007/s002130000566 Everitt, 2001, The neuropsychological basis of addictive behaviour, Brain Res Rev, 36, 129, 10.1016/S0165-0173(01)00088-1 Fadda, 2003, Baclofen antagonizes nicotine-, cocaine-, and morphine-induced dopamine release in the nucleus accumbens of rat, Synapse, 50, 1, 10.1002/syn.10238 Fattore, 2002, Baclofen antagonizes intravenous self-administration of nicotine in mice and rats, Alcohol Alcohol, 37, 495, 10.1093/alcalc/37.5.495 Fischman, 1982, Cocaine self-administration in humans, Fed Proc, 41, 241 Fischman, 1988, Human drug taking under controlled laboratory conditions, NIDA Res Monogr, 84, 196 Flannery, 2004, Baclofen for alcohol dependence: a preliminary open-label study, Alcohol Clin Exp Res, 28, 1517, 10.1097/01.ALC.0000141640.48924.14 Foltin, 1992, Self-administration of cocaine by humans: choice between smoked and intravenous cocaine, J Pharmacol Exp Ther, 261, 841 French, 1995, A comparison of the reinforcing efficacy of PCP, the PCP derivatives TCP and BTCP, and cocaine using a progressive ratio schedule in the rat, Behav Pharmacol, 6, 223, 10.1097/00008877-199504000-00002 Gaddum, 1961, Push–pull cannulae, J Physiol, 155, P1 Gaddum, 1962, Substances released in nervous activity, 1 Gál, 2003, Targeting the dopamine D3 receptor cannot influence continuous reinforcement cocaine self-administration in rats, Brain Res Bull, 61, 595, 10.1016/S0361-9230(03)00217-X Gallistel, 1981, A portrait of the brain for self-stimulation, Psychol Rev, 88, 228, 10.1037/0033-295X.88.3.228 Garbutt, 2005, Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial, JAMA, 293, 1617, 10.1001/jama.293.13.1617 Gardner, 1971, An improved technique for determining brain reward thresholds in primates, Behav Res Meth Instrum, 3, 273, 10.3758/BF03208404 Gardner, 2000, What we have learned about addiction from animal models of drug self-administration, Am J Addict, 9, 285, 10.1080/105504900750047355 Gardner, 2002, Addictive potential of cannabinoids: the underlying neurobiology, Chem Phys Lipids, 121, 267, 10.1016/S0009-3084(02)00162-7 Gardner, 2005, Brain-reward mechanisms, 48 Gardner, 1993, Overview of chemical sampling techniques, J Neurosci Methods, 48, 173, 10.1016/0165-0270(93)90091-5 Gardner, 2002, Gamma-vinyl GABA, an irreversible inhibitor of GABA transaminase, alters the acquisition and expression of cocaine-induced sensitization in male rats, Synapse, 46, 240, 10.1002/syn.10138 Geeraedts, 1990, Medial forebrain bundle of the rat: III. Cytoarchitecture of the rostral (telencephalic) part of the medial forebrain bundle bed nucleus, J Comp Neurol, 294, 507, 10.1002/cne.902940403 Gerasimov, 1999, Gamma-vinyl γ-aminobutyric acid attenuates the synergistic elevations of nucleus accumbens dopamine produced by a cocaine/heroin (speedball) challenge, Eur J Pharmacol, 380, 1, 10.1016/S0014-2999(99)00526-9 Gerasimov, 1999, Gamma-vinyl GABA inhibits methamphetamine, heroin, or ethanol-induced increases in nucleus accumbens dopamine, Synapse, 34, 11, 10.1002/(SICI)1098-2396(199910)34:1<11::AID-SYN2>3.0.CO;2-5 Gerasimov, 2000, γ-Aminobutyric acid mimetic drugs differentially inhibit the dopaminergic response to cocaine, Eur J Pharmacol, 395, 129, 10.1016/S0014-2999(00)00267-3 Gerasimov, 2001, GABAergic blockade of cocaine-associated cue-induced increases in nucleus accumbens dopamine, Eur J Pharmacol, 414, 205, 10.1016/S0014-2999(01)00800-7 Gerber, 1975, Drug-induced reinstatement of extinguished self-administration behavior in monkeys, Pharmacol Biochem Behav, 3, 1055, 10.1016/0091-3057(75)90016-7 Gerfen, 1992, The neostriatal mosaic: multiple levels of compartmental organization, Trends Neurosci, 15, 133, 10.1016/0166-2236(92)90355-C Gervin, 1999, Dysphoric subjective response to neuroleptics in schizophrenia: relationship to extrapyramidal side effects and symptomatology, Eur Psychiatry, 14, 405, 10.1016/S0924-9338(99)00228-X Gilbert, 2003, The dopamine D3 receptor antagonist SB277011A inhibits cocaine reinforcement under fixed ratio and progressive ratio schedules Gilbert, 2005, Acute administration of SB-277011A, NGB 2904, or BP 897 inhibits cocaine cue-induced reinstatement of drug-seeking behavior in rats: role of dopamine D3 receptors, Synapse, 57, 17, 10.1002/syn.20152 Glick, 1975, Changes in morphine self-administration and morphine dependence after lesions of the caudate nucleus in rats, Psychopharmacologia, 41, 219, 10.1007/BF00428927 Goeders, 1983, Cortical dopaminergic involvement in cocaine reinforcement, Science, 221, 773, 10.1126/science.6879176 Goeders, 1986, Reinforcing properties of cocaine in the medial prefrontal cortex: primary action on presynaptic dopaminergic terminals, Pharmacol Biochem Behav, 25, 191, 10.1016/0091-3057(86)90252-2 Goeders, 1993, Intracranial cocaine self-administration into the medial prefrontal cortex increases dopamine turnover in the nucleus accumbens, J Pharmacol Exp Ther, 265, 592 Goeders, 1984, Self-administration of methionine enkephalin into the nucleus accumbens, Pharmacol Biochem Behav, 20, 451, 10.1016/0091-3057(84)90284-3 Goeders, 1986, Neuropharmacological assessment of cocaine self-administration into the medial prefrontal cortex, Pharmacol Biochem Behav, 24, 1429, 10.1016/0091-3057(86)90206-6 Goldberg, 1973, Comparable behavior maintained under fixed-ratio and second-order schedules of food presentation, cocaine injection or d-amphetamine injection in the squirrel monkey, J Pharmacol Exp Ther, 186, 18 Goldberg, 1970, Conditioned morphine-induced abstinence changes: persistence in post morphine-dependent monkeys, J Exp Anal Behav, 14, 33, 10.1901/jeab.1970.14-33 Goldberg, 1977, Behavior maintained under second-order schedules of intravenous morphine injection in squirrel and rhesus monkeys, Psychopharmacology, 51, 235, 10.1007/BF00431630 Goldberg, 1971, Aversive properties of nalorphine and naloxone in morphine-dependent rhesus monkeys, J Pharmacol Exp Ther, 179, 268 Gorelick, 2004, Agents in development for the management of cocaine abuse, Drugs, 64, 1547, 10.2165/00003495-200464140-00004 Gracy, 2001, Opiate withdrawal-induced fos immunoreactivity in the rat extended amygdala parallels the development of conditioned place aversion, Neuropsychopharmacology, 24, 152, 10.1016/S0893-133X(00)00186-X Graf Schimmelmann, 2004, Die initial dysphorische reaktion (IDR) auf die ersteinnahme von neuroleptika, Nervenarzt, 75, 36, 10.1007/s00115-003-1544-z Grant, 1996, Activation of memory circuits during cue-elicited cocaine craving, Proc Natl Acad of Sci U S A, 93, 12040, 10.1073/pnas.93.21.12040 Graybiel, 1990, Neurotransmitters and neuromodulators in the basal ganglia, Trends Neurosci, 13, 244, 10.1016/0166-2236(90)90104-I Griffiths, 1978, Experimental drug self-administration: generality across species and type of drug, NIDA Res Monogr, 20, 24 Griffiths, 1979, Human drug self-administration: double-blind comparison of pentobarbital, diazepam, chlorpromazine and placebo, J Pharmacol Exp Ther, 210, 301 Griffiths, 1979, Predicting the abuse liability of drugs with animal drug self-administration procedures: psychomotor stimulants and hallucinogens, Adv Behav Pharmacol, 2, 163, 10.1016/B978-0-12-004702-4.50010-2 Grimm, 2000, Dissociation of primary and secondary reward-relevant limbic nuclei in an animal model of ability of relapse, Neuropsychopharmacology, 22, 473, 10.1016/S0893-133X(99)00157-8 Grundt, 2004, Novel dopamine D3 receptor ligands as tools for in vivo evaluation Gutstein, 2001, Opioid analgesics, 569 Haertzen, 1987, Addiction Research Center Inventory (ARCI): measurement of euphoria and other drug effects, 489 Hart, 2002, Effects of oral THC maintenance on smoked marijuana self-administration, Drug Alcohol Depend, 67, 301, 10.1016/S0376-8716(02)00084-4 Hayes, 2004, The basolateral complex of the amygdala mediates the modulation of intracranial self-stimulation threshold by drug-associated cues, Eur J Neurosci, 20, 273, 10.1111/j.1460-9568.2004.03463.x Hayes, 2003, Electrical and chemical stimulation of the basolateral complex of the amygdala reinstates cocaine-seeking behavior in the rat, Psychopharmacology, 168, 75, 10.1007/s00213-002-1328-3 Heath, 1964, Pleasure response of human beings to direct stimulation of the brain: physiologic and psychodynamic considerations, 219 Heidbreder, 2005, The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidence, Brain Res Brain Res Rev, 49, 77, 10.1016/j.brainresrev.2004.12.033 Heimer, 1991, Specificity of the projection patterns of accumbal core and shell in the rat, Neuroscience, 41, 89, 10.1016/0306-4522(91)90202-Y Heit, 2003, Addiction, physical dependence, and tolerance: precise definitions to help clinicians evaluate and treat chronic pain patients, J Pain Palliat Care Pharmacother, 17, 15, 10.1080/J354v17n01_03 Henriksen, 1992, Properties of neurons recorded in the rodent nucleus accumbens, in vivo: relationship to behavioral state and heroin self-administration, Soc Neurosci Abstr, 18, 373 Hiroi, 1991, The lateral nucleus of the amygdala mediates expression of the amphetamine-produced conditioned place preference, J Neurosci, 11, 2107, 10.1523/JNEUROSCI.11-07-02107.1991 Hodos, 1961, Progressive ratio as a measure of reward strength, Science, 134, 943, 10.1126/science.134.3483.943 Hoebel, 1969, Feeding and self-stimulation, Ann N Y Acad Sci, 157, 758, 10.1111/j.1749-6632.1969.tb12919.x Hoebel, 1962, Hypothalamic control of feeding and self-stimulation, Science, 135, 375, 10.1126/science.135.3501.375 Hoffmeister, 1975, Psychotropic drugs as negative reinforcers, Pharmacol Rev, 27, 419 Holtzman, 2003, Discrimination of a single dose of morphine followed by naltrexone: substitution of other agonists for morphine and other antagonists for naltrexone in a rat model of acute dependence, J Pharmacol Exp Ther, 304, 1033, 10.1124/jpet.102.044875 Hooks, 1994, Behavioral and neurochemical sensitization following cocaine self-administration, Psychopharmacology, 115, 265, 10.1007/BF02244782 Hows, 2004, High-performance liquid chromatography/tandem mass spectrometric assay for the simultaneous measurement of dopamine, norepinephrine, 5-hydroxytryptamine and cocaine in biological samples, J Neurosci Methods, 138, 123, 10.1016/j.jneumeth.2004.03.021 Hyman, 2001, Addiction and the brain: the neurobiology of compulsion and its persistence, Nat Rev Neurosci, 2, 695, 10.1038/35094560 Ikemoto, 2003, Involvement of the olfactory tubercle in cocaine reward: intracranial self-administration studies, J Neurosci, 23, 9305, 10.1523/JNEUROSCI.23-28-09305.2003 Ikemoto, 1999, The role of nucleus accumbens dopamine in motivated behavior: a unifying interpretation with special reference to reward-seeking, Brain Res Rev, 31, 6, 10.1016/S0165-0173(99)00023-5 Ikemoto, 2004, Mapping of chemical trigger zones for reward, Neuropharmacology, 47, 190, 10.1016/j.neuropharm.2004.07.012 Ikemoto, 1997, Role of dopamine D1 and D2 receptors in the nucleus accumbens in mediating reward, J Neurosci, 17, 8580, 10.1523/JNEUROSCI.17-21-08580.1997 Janak, 2003, Comparison of the effects of allopregnanolone with direct GABAergic agonists on ethanol self-administration with and without concurrently available sucrose, Alcohol, 30, 1, 10.1016/S0741-8329(03)00068-5 Jarema, 2001, Subiektywna i obiektywna ocena schizofrenii lekami klasycznymi i atypowymi, Psychiatr Pol, 35, 5 Jarema, 2004, Porównanie subiektywnej i obiektywnej oceny leczenia olanzapin chorych na schizofreni, Psychiatr Pol, 38, 895 Jasinski, 2000, Evaluation of the abuse liability of modafinil and other drugs for excessive daytime sleepiness associated with narcolepsy, Clin Neuropharmacol, 23, 149, 10.1097/00002826-200005000-00004 Johnson, 2004, Progress in the development of topiramate for treating alcohol dependence: from a hypothesis to a proof-of-concept study, Alcohol Clin Exp Res, 28, 1137, 10.1097/01.ALC.0000134533.96915.08 Johnson, 1993, Regional reward differences within the ventral pallidum are revealed by microinjections of a mu opiate receptor agonist, Neuropharmacology, 32, 1305, 10.1016/0028-3908(93)90025-X Johnson, 1993, Neuroleptic dysphopria: in search of an animal model, Int J Neurosci, 70, 271, 10.3109/00207459309000581 Johnson, 1995, Reward shifts and motor responses following microinjections of opiate-specific agonists into either the core or shell of the nucleus accumbens, Psychopharmacology, 120, 195, 10.1007/BF02246193 Joseph, 2003, The interpretation of the measurement of nucleus accumbens dopamine by in vivo dialysis: the kick, the craving or the cognition?, Neurosci Biobehav Rev, 27, 527, 10.1016/j.neubiorev.2003.09.001 Jung, 1977, γ-Vinyl GABA (4-amino-hex-5-enoic acid), a new selective inhibitor of GABA-T: effects on brain GABA metabolism in mice, J Neurochem, 29, 797, 10.1111/j.1471-4159.1977.tb10721.x Kalivas, 2003, Brain circuitry and the reinstatement of cocaine-seeking behavior, Psychopharmacology, 168, 44, 10.1007/s00213-003-1393-2 Kalivas, 1990, Modulation of A10 dopamine neurons by gamma-aminobutyric acid agonists, J Pharmacol Exp Ther, 253, 858 Kalivas, 1993, GABA and enkephalin projection from the nucleus accumbens and ventral pallidum to the ventral tegmental area, Neuroscience, 57, 1047, 10.1016/0306-4522(93)90048-K Kampman, 2004, A pilot trial of topiramate for the treatment of cocaine dependence, Drug Alcohol Depend, 75, 233, 10.1016/j.drugalcdep.2004.03.008 Kandel, 1977, An investigation of nalorphine and perphenazine as negative reinforcers in an escape paradigm, Pharmacol Biochem Behav, 6, 61, 10.1016/0091-3057(77)90160-5 Katner, 1999, Ethanol-associated olfactory stimuli reinstate ethanol-seeking behavior after extinction and modify extracellular dopamine levels in the nucleus accumbens, Alcohol Clin Exp Res, 23, 1751, 10.1111/j.1530-0277.1999.tb04070.x Katner, 1999, Reinstatement of alcohol-seeking behavior by drug-associated discriminative stimuli after prolonged extinction in the rat, Neuropsychopharmacology, 20, 471, 10.1016/S0893-133X(98)00084-0 Kawaguchi, 1995, Striatal interneurones: chemical physiological and morphological characterization, Trends Neurosci, 18, 527, 10.1016/0166-2236(95)98374-8 Killam, 1957, Further studies on the effects of centrally acting drugs on self-stimulation, J Pharmacol Exp Ther, 119, 157 King, 1995, Antipsychotic drug-induced dysphoria, Br J Psychiatry, 167, 480, 10.1192/bjp.167.4.480 Kissinger, 1990, Optimization of LC apparatus for determinations in neurochemistry with an emphasis on microdialysis samples, J Neurosci Methods, 34, 3, 10.1016/0165-0270(90)90035-E Kissinger, 1973, Voltammetry in brain tissue: a new neurophysiological measurement, Brain Res, 55, 209, 10.1016/0006-8993(73)90503-9 Kiyatkin, 1999, Modulation of striatal neuronal activity by glutamate and GABA: iontophoresis in awake, unrestrained rats, Brain Res, 822, 88, 10.1016/S0006-8993(99)01093-8 Klitenick, 1992, Regulation of somatodendritic dopamine release in the ventral tegmental area by opioids and GABA: an in vivo microdialysis study, J Neurosci, 12, 2623, 10.1523/JNEUROSCI.12-07-02623.1992 Koob, 1992, Drugs of abuse: anatomy, pharmacology and function of reward pathways, Trends Pharmacol Sci, 13, 177, 10.1016/0165-6147(92)90060-J Koob, 2000, Neurobiology of addiction. Toward the development of new therapies, Ann N Y Acad Sci, 909, 170, 10.1111/j.1749-6632.2000.tb06682.x Koob, 1987, Positive reinforcement properties of drugs: search for neural substrates, 35 Kornetsky, 1985, Brain-stimulation reward: a model for the neuronal bases for drug-induced euphoria, NIDA Res Monogr, 62, 30 Kornetsky, 1979, Euphorigenic drugs: effects on the reward pathways of the brain, Fed Proc, 38, 2473 Kornetsky, 1991, The role the olfactory tubercle in the effects of cocaine, morphine, and brain-stimulation reward, Brain Res, 541, 75, 10.1016/0006-8993(91)91076-D Kushner, 1997, Gamma-vinyl-GABA attenuates cocaine-induced lowering of brain-stimulation reward thresholds, Psychopharmacology, 133, 383, 10.1007/s002130050418 Kushner, 1999, The irreversible γ-aminobutyric acid (GABA) transaminase inhibitor γ-vinyl-GABA blocks cocaine self-administration in rats, J Pharmacol Exp Ther, 290, 797 Lamb, 1991, The reinforcing and subjective effects of morphine in post-addicts: a dose–response study, J Pharmacol Exp Ther, 259, 1165 Lambert, 2003, Subjective well-being and initial dysphoric reaction under antipsychotic drugs—concepts, measurement and clinical relevance, Pharmacopsychiatry, 36, S181 LeDoux, 1993, Emotional memory systems in the brain, Behav Brain Res, 58, 69, 10.1016/0166-4328(93)90091-4 LeDoux, 1997, How the brain processes emotional information, Ann N Y Acad Sci, 821, 259, 10.1111/j.1749-6632.1997.tb48285.x LeDoux, 2000, Emotional circuits in the brain, Annu Rev Neurosci, 23, 155, 10.1146/annurev.neuro.23.1.155 Lee, 1999, Cellular responses of nucleus accumbens neurons to opiate-seeking behavior: I. Sustained responding during heroin self-administration, Synapse, 33, 49, 10.1002/(SICI)1098-2396(199907)33:1<49::AID-SYN5>3.0.CO;2-O Lee, 2004, Gamma-vinyl GABA (vigabatrin) blocks the expression of toluene-induced conditioned place preference (CPP), Synapse, 54, 183, 10.1002/syn.20072 Le Foll, 2002, Role of the dopamine D3 receptor in reactivity to cocaine-associated cues in mice, Eur J Neurosci, 15, 2016, 10.1046/j.1460-9568.2002.02049.x Leite-Morris, 2004, GABAB receptor activation in the ventral tegmental area inhibits the acquisition and expression of opiate-induced motor sensitization, J Pharmacol Exp Ther, 308, 667, 10.1124/jpet.103.058412 Lepore, 1992, Modelling drug kinetics with brain stimulation: dopamine antagonists increase self-stimulation, Pharmacol Biochem Behav, 41, 489, 10.1016/0091-3057(92)90362-J Lepore, 1996, Genetic differences in Δ9-tetrahydrocannabinol-induced facilitation of brain stimulation reward as measured by a rate–frequency curve-shift electrical brain stimulation paradigm in three different rat strains, Life Sci [Pharmacol Lett], 58, PL365, 10.1016/0024-3205(96)00237-8 Levant, 1998, Differential distribution of D3 dopamine receptors in the brains of several mammalian species, Brain Res, 800, 269, 10.1016/S0006-8993(98)00529-0 Lévesque, 1992, Identification, characterization, and localization of the dopamine D3 receptor in rat brain using 7-[3H]hydroxy-N,N-di-n-propyl-2-aminotetralin, Proc Natl Acad Sci U S A, 89, 8155, 10.1073/pnas.89.17.8155 Li, 2001, GABAB receptor agonist baclofen attenuates the development and expression of d-methamphetamine-induced place preference in rats, Life Sci, 70, 349, 10.1016/S0024-3205(01)01397-2 Lile, 2004, Baclofen does not alter the reinforcing, subject-rated or cardiovascular effects of intranasal cocaine in humans, Psychopharmacology, 171, 441, 10.1007/s00213-003-1598-4 Lin, 1996, Neonatal exposure to cocaine enhances the reward-potentiating properties of the drug in young adult animals, Behav Neurosci, 110, 791, 10.1037/0735-7044.110.4.791 Ling, 1998, Baclofen as a cocaine anti-craving medication: a preliminary clinical study, Neuropsychopharmacology, 18, 403 Lu, 2000, Corticotropin-releasing factor receptor type I mediates stress-induced relapse to opiate dependence in rats, NeuroReport, 11, 2373, 10.1097/00001756-200008030-00008 Lyness, 1979, Destruction of dopaminergic nerve terminals in nucleus accumbens: effect on d-amphetamine self-administration, Pharmacol Biochem Behav, 11, 553, 10.1016/0091-3057(79)90040-6 Maidment, 1989, Microdialysis of extracellular endogenous opioid peptides from rat brain in vivo, Neuroscience, 33, 549, 10.1016/0306-4522(89)90407-7 Maldonado, 2004, GHB ameliorates naloxone-induced conditioned place aversion and physical aspects of morphine withdrawal in mice, Psychopharmacology (Berl), 177, 130, 10.1007/s00213-004-1927-2 Maldonado-Irizarry, 1996, Blockade of D-1 and D-2 dopamine receptors attenuates ‘relapse’ elicited by cocaine-associated environmental stimuli following prolonged extinction, Soc Neurosci Abstr, 22, 925 Maneuf, 1994, On the role of enkephalin cotransmission in the GABAergic striatal efferents to the globus pallidus, Exp Neurol, 125, 65, 10.1006/exnr.1994.1007 Marcon, 2003, A new model to assess drug and cue-induced relapse to ethanol self-administration in mice, Behav Pharmacol, 14, S66 Margules, 1962, Identical ‘feeding’ and ‘rewarding’ systems in the lateral hypothalamus of rats, Science, 135, 374, 10.1126/science.135.3501.374 Markou, 1993, Animal models of drug craving, Psychopharmacology, 112, 163, 10.1007/BF02244907 Markou, 2004, Role of γ-aminobutyric acid (GABA) and metabotropic glutamate receptors in nicotine reinforcement: potential pharmacotherapies for smoking cessation, Ann N Y Acad Sci, 1025, 491, 10.1196/annals.1316.061 Martin, 2000, Effects of reward anticipation, reward presentation, and spatial parameters on the firing of single neurons recorded in the subiculum and nucleus accumbens of freely moving rats, Behav Brain Res, 116, 23, 10.1016/S0166-4328(00)00249-7 Mattson, 1995, Vigabatrin: effect on brain GABA levels measured by nuclear magnetic resonance spectroscopy, Acta Neurol Scand Suppl, 162, 27 McFarland, 1997, Reinstatement of drug-seeking behavior produced by heroin-predictive environmental stimuli, Psychopharmacology, 131, 86, 10.1007/s002130050269 McFarland, 2000, The circuitry mediating cocaine-induced reinstatement of drug-seeking behavior, J Neurosci, 21, 8655, 10.1523/JNEUROSCI.21-21-08655.2001 Meil, 1996, Conditioned cued recovery of responding following prolonged withdrawal from self-administered cocaine in rats: an animal model of relapse, Behav Pharmacol, 7, 754 Meil, 1997, Lesions of the basolateral amygdala abolish the ability of drug associated cues to reinstate responding during withdrawal from self-administered cocaine, Behav Brain Res, 87, 139, 10.1016/S0166-4328(96)02270-X Mello, 1965, Operant drinking of alcohol on a rate-contingent ratio schedule of reinforcement, J Psychiatr Res, 3, 145, 10.1016/0022-3956(65)90024-5 Meredith, 1999, The synaptic framework for chemical signalling in nucleus accumbens, Ann N Y Acad Sci, 877, 140, 10.1111/j.1749-6632.1999.tb09266.x Meyer, 1979 Miliaressis, 1986, The curve-shift paradigm in self-stimulation, Physiol Behav, 37, 85, 10.1016/0031-9384(86)90388-4 Mogenson, 1980, From motivation to action: functional interface between the limbic system and the motor system, Prog Neurobiol, 14, 69, 10.1016/0301-0082(80)90018-0 Moore, 1979, Central catecholamine neuron systems: anatomy and physiology of the norepinephrine and epinephrine systems, Annu Rev Neurosci, 2, 113, 10.1146/annurev.ne.02.030179.000553 Morgan, 1998, Effects of pharmacologic increases in brain GABA levels on cocaine-induced changes in extracellular dopamine, Synapse, 28, 60, 10.1002/(SICI)1098-2396(199801)28:1<60::AID-SYN7>3.0.CO;2-A Morgan, 2004, Sensitization to the reinforcing effects of cocaine following binge-abstinent self-administration, Neurosci Biobehav Rev, 27, 803, 10.1016/j.neubiorev.2003.11.004 Mueller, 2000, Cocaine-induced conditioned place preference: reinstatement by priming injections of cocaine after extinction, Behav Brain Res, 115, 39, 10.1016/S0166-4328(00)00239-4 Mueller, 2002, Persistence and drug-induced reinstatement of a morphine-induced conditioned place preference, Behav Brain Res, 136, 389, 10.1016/S0166-4328(02)00297-8 Muller, 1997, Functional inactivation of the lateral and basal nuclei of the amygdala by muscimol infusion prevents fear conditioning to an explicit conditioned stimulus and to contextual stimuli, Behav Neurosci, 111, 683, 10.1037/0735-7044.111.4.683 Murray, 1996, Physiological measures of conduction velocity and refractory period for putative reward-relevant MFB axons arising in the rostral MFB, Physiol Behav, 59, 427, 10.1016/0031-9384(95)02077-2 Murray, 1996, Behavioral measures of conduction velocity and refractory period for reward-relevant axons in the anterior LH and VTA, Physiol Behav, 59, 643, 10.1016/0031-9384(96)80249-6 Murray, 1996, Attenuation of medial forebrain bundle reward by anterior lateral-hypothalamic lesions, Behav Brain Res, 75, 33, 10.1016/0166-4328(96)00155-6 Nader, 1999, Inhibition of the mesoamygdala dopaminergic pathway impairs the retrieval of conditioned fear associations, Behav Neurosci, 113, 891, 10.1037/0735-7044.113.5.891 Nakajima, 1989, Subtypes of dopamine receptors involved in the mechanism of reinforcement, Neurosci Biobehav Rev, 13, 123, 10.1016/S0149-7634(89)80020-X Nakajima, 1993, Synergistic interaction of D1 and D2 dopamine receptors in the modulation of the reinforcing effect of brain stimulation, Behav Neurosci, 107, 161, 10.1037/0735-7044.107.1.161 Nazzaro, 1980, GABA antagonism lowers self-stimulation thresholds in the ventral tegmental area, Brain Res, 189, 279, 10.1016/0006-8993(80)90029-3 Nazzaro, 1980, Naloxone blocks phencyclidine's dose-dependent effects on direct brain reward thresholds, 949 Neisewander, 2004, Increases in dopamine D3 receptor binding in rats receiving a cocaine challenge at various time points after cocaine self-administration: implications for cocaine-seeking behavior, Neuropsychopharmacology, 29, 1479, 10.1038/sj.npp.1300456 Nestler, 2004, Molecular mechanisms of drug addiction, Neuropharmacology, 47, 24, 10.1016/j.neuropharm.2004.06.031 Newman, 2003, N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl, butenyl and butynyl}arylcarboxamides as novel dopamine D3 receptor antagonists, Bioorg Med Chem Lett, 13, 2179, 10.1016/S0960-894X(03)00389-5 O'Brien, 1975, Experimental analysis of conditioning factors in human narcotic addiction, Pharmacol Rev, 27, 535 O'Brien, 1997, A range of research-based pharmacotherapies for addiction, Science, 278, 66, 10.1126/science.278.5335.66 O'Brien, 2001, Drug addiction and drug abuse, 621 O'Brien, 2005, Anticraving medications for relapse prevention: a possible new class of psychoactive medications, Am J Psychiatry, 162, 1423, 10.1176/appi.ajp.162.8.1423 O'Brien, 1975, Clinical experience with naltrexone, Am J Drug Alcohol Abuse, 2, 365, 10.3109/00952997509005662 O'Brien, 1977, Conditioned narcotic withdrawal in humans, Science, 195, 1000, 10.1126/science.841320 O'Brien, 1979, Unreinforced self-injections: effects on rituals and outcome in heroin addicts, NIDA Res Monogr, 27, 275 O'Brien, 1984, Use of naltrexone to extinguish opioid-conditioned responses, J Clin Psychiatry, 45, 53 O'Brien, 1986, Classical conditioning in human opioid dependence, 329 Olds, 1959, Self-stimulation experiments and differentiated reward systems, 671 Olds, 1979, Hypothalamic substrate for the positive reinforcing properties of morphine in the rat, Brain Res, 168, 351, 10.1016/0006-8993(79)90175-6 Olds, 1982, Reinforcing effects of morphine in the nucleus accumbens, Brain Res, 237, 429, 10.1016/0006-8993(82)90454-1 Olds, 1954, Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain, J Comp Physiol Psychol, 47, 419, 10.1037/h0058775 Olds, 1963, Approach–avoidance analysis of rat diencephalon, J Comp Neurol, 120, 259, 10.1002/cne.901200206 Olds, 1965, Drives, rewards and the brain, 329 Olds, 1980, Self-administration of d-ala2-met-enkephalinamide at hypothalamic self stimulation sites, Brain Res, 194, 155, 10.1016/0006-8993(80)91325-6 O'Malley, 1992, Naltrexone and coping skills therapy for alcohol dependence: a controlled study, Arch Gen Psychiatry, 49, 881, 10.1001/archpsyc.1992.01820110045007 Panagis, 2002, The effects of ventral tegmental administration of GABAA, GABAB, NMDA and AMPA receptor agonists on ventral pallidum self-stimulation, Behav Brain Res, 131, 115, 10.1016/S0166-4328(01)00353-9 Panagis, 1998, Involvement of the ventral tegmental area opiate receptors in self-stimulation elicited from the ventral pallidum, Psychopharmacology, 139, 222, 10.1007/s002130050708 Pappagallo, 1998, The concept of pseudotolerance, J Pharm Care Pain Symptom Control, 6, 95, 10.1300/J088v06n02_07 Park, 2002, Cocaine administered into the medial prefrontal cortex reinstates cocaine-seeking behavior by increasing AMPA receptor-mediated glutamate transmission in the nucleus accumbens, J Neurosci, 22, 2916, 10.1523/JNEUROSCI.22-07-02916.2002 Parrot, 2003, Microdialysis monitoring of catecholamines and excitatory amino acids in the rat and mouse brain: recent developments based on capillary electrophoresis with laser-induced fluorescence detection—a mini-review, Cell Mol Neurobiol, 23, 793, 10.1023/A:1025009221285 Parsons, 1996, Neurochemical evidence that postsynaptic nucleus accumbens D3 receptor stimulation enhances cocaine reinforcement, J Neurochem, 67, 1078, 10.1046/j.1471-4159.1996.67031078.x Paterson, 2004, The GABAB receptor agonists baclofen and CGP44532 decreased nicotine self-administration in the rat, Psychopharmacology, 172, 179, 10.1007/s00213-003-1637-1 Paterson, 2005, Repeated administration of the GABAB receptor agonist CGP44532 decreased nicotine self-administration, and acute administration decreased cue-induced reinstatement of nicotine-seeking in rats, Neuropsychopharmacology, 30, 119, 10.1038/sj.npp.1300524 Paul, 2001, Gamma-vinyl GABA (GVG) blocks expression of the conditioned place preference response to heroin in rats, Synapse, 41, 219, 10.1002/syn.1078 Peng, 2004, Gamma-vinyl GABA, but not gabapentin, inhibits cocaine-triggered reinstatement of drug-seeking behavior in the rat Peoples, 2003, Differential changes in signal and background firing of accumbal neurons during cocaine self-administration, J Neurophysiol, 90, 993, 10.1152/jn.00849.2002 Peoples, 1996, Phasic firing of single neurons in the rat nucleus accumbens correlated with the timing of intravenous cocaine self-administration, J Neurosci, 16, 3459, 10.1523/JNEUROSCI.16-10-03459.1996 Peoples, 1997, Operant behavior during sessions of intravenous cocaine infusion is necessary and sufficient for phasic firing of single nucleus accumbens neurons, Brain Res, 757, 280, 10.1016/S0006-8993(97)00299-0 Peoples, 1998, Tonic inhibition of single nucleus accumbens neurons in the rat: a predominant but not exclusive firing pattern induced by cocaine self-administration sessions, Neuroscience, 86, 13, 10.1016/S0306-4522(98)00116-X Peoples, 1998, Phasic firing time locked to cocaine self-infusion and locomotion: dissociable firing patterns of single nucleus accumbens neurons in the rat, J Neurosci, 18, 7588, 10.1523/JNEUROSCI.18-18-07588.1998 Peoples, 1999, Phasic accumbal firing may contribute to the regulation of drug taking during intravenous cocaine self-administration sessions, Ann N Y Acad Sci, 877, 781, 10.1111/j.1749-6632.1999.tb09322.x Pettit, 1989, Dopamine in the nucleus accumbens during cocaine self-administration as studied by in vivo microdialysis, Pharmacol Biochem Behav, 34, 899, 10.1016/0091-3057(89)90291-8 Pettit, 1991, Effect of dose on cocaine self-administration behavior and dopamine levels in the nucleus accumbens, Brain Res, 539, 94, 10.1016/0006-8993(91)90690-W Phillips, 1983, Strategies for studying the neurochemical substrates of drug reinforcement in rodents, Prog Neuropsychopharmacol Biol Psychiatry, 7, 585, 10.1016/0278-5846(83)90029-5 Phillips, 1992, Self-stimulation of the ventral tegmental area enhances dopamine release in the nucleus accumbens: a microdialysis study, Ann N Y Acad Sci, 654, 199, 10.1111/j.1749-6632.1992.tb25968.x Pilla, 1999, Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist, Nature, 400, 371, 10.1038/22560 Post, 1976, Increasing effects of repetitive cocaine administration in the rat, Nature, 260, 731, 10.1038/260731a0 Prosser, 1987, Depression, parkinsonian symptoms, and negative symptoms in schizophrenics treated with neuroleptics, J Nerv Ment Dis, 175, 100, 10.1097/00005053-198702000-00006 Rada, 1998, Dopamine release in the nucleus accumbens by hypothalamic stimulation-escape behavior, Brain Res, 782, 228, 10.1016/S0006-8993(97)01283-3 Ramaekers, 1999, Psychomotor, cognitive, extrapyramidal, and affective functions of healthy volunteers during treatment with an atypical (amisulpride) and a classic (haloperidol) antipsychotic, J Clin Psychopharmacol, 19, 209, 10.1097/00004714-199906000-00003 Ranaldi, 2002, Baclofen decreases methamphetamine self-administration in rats, NeuroReport, 13, 1107, 10.1097/00001756-200207020-00007 Ranaldi, 1994, Automating the generation and collection of rate–frequency functions in a curve-shift brain stimulation reward paradigm, J Neurosci Methods, 53, 163, 10.1016/0165-0270(94)90174-0 Reavill, 2000, Pharmacological actions of a novel, high-affinity, and selective human dopamine D3 receptor antagonist, SB-277011-A, J Pharmacol Exp Ther, 294, 1154 Richardson, 1996, Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy, J Neurosci Methods, 66, 1, 10.1016/0165-0270(95)00153-0 Rivera, 2003, A novel dopamine D3 receptor antagonist (SB-277011-A) attenuates ethanol consumption in ethanol preferring (P) and non-preferring (NP) rats Robarge, 2001, Design and synthesis of [(2,3-dichlorophenyl)piperazin-1-yl]alkylfluorenylcarboxamides as novel ligands selective for the dopamine D3 receptor subtype, J Med Chem, 44, 3175, 10.1021/jm010146o Robbins, 2002, Limbic-striatal memory systems and drug addiction, Neurobiol Learn Mem, 78, 625, 10.1006/nlme.2002.4103 Roberts, 1989, Breaking points on a progressive ratio schedule reinforced by intravenous apomorphine increase daily following 6-hydroxydopamine lesions of the nucleus accumbens, Pharmacol Biochem Behav, 32, 43, 10.1016/0091-3057(89)90208-6 Roberts, 1997, Baclofen suppression of cocaine self-administration: demonstration using a discrete trials procedure, Psychopharmacology, 131, 271, 10.1007/s002130050293 Roberts, 1993, Heroin self-administration in rats under a progressive ratio schedule of reinforcement, Psychopharmacology, 111, 215, 10.1007/BF02245526 Roberts, 2000, GABA modulation of cocaine self-administration, Ann N Y Acad Sci, 909, 155 Roberts, 1982, Disruption of cocaine self-administration following 6-hydroxydopamine lesions of the ventral tegmental area, Pharmacol Biochem Behav, 17, 901, 10.1016/0091-3057(82)90469-5 Roberts, 1987, Interpretation of lesion effects on stimulant self-administration, 87 Roberts, 1977, On the role of ascending catecholamine systems in self-administration of cocaine, Pharmacol Biochem Behav, 6, 615, 10.1016/0091-3057(77)90084-3 Roberts, 1980, Extinction and recovery of cocaine self-administration following 6-hydroxydopamine lesions of the nucleus accumbens, Pharmacol Biochem Behav, 12, 781, 10.1016/0091-3057(80)90166-5 Roberts, 1996, Baclofen attenuates the reinforcing effects of cocaine, Neuropsychopharmacology, 15, 417, 10.1016/0893-133X(96)00002-4 Roberts, 1996, Baclofen attenuates the reinforcing effects of cocaine in rats, Neuropsychopharmacology, 15, 417, 10.1016/0893-133X(96)00002-4 Robinson, 2003, Addiction, Annu Rev Psychol, 54, 25, 10.1146/annurev.psych.54.101601.145237 Robinson, 2003, Detecting subsecond dopamine release with fast-scan cyclic voltammetry in vivo, Clin Chem, 49, 1763, 10.1373/49.10.1763 Robledo, 1993, Two discrete nucleus accumbens projection areas differentially mediate cocaine self-administration in the rat, Behav Brain Res, 55, 159, 10.1016/0166-4328(93)90112-4 Romach, 1999, Attenuation of the euphoric effects of cocaine by the dopamine D1/D5 antagonist ecopipam (SCH39166), Arch Gen Psychiatry, 56, 1101, 10.1001/archpsyc.56.12.1101 Routtenberg, 1965, Effects of the availability of rewarding septal and hypothalamic stimulation on bar-pressing for food under conditions of deprivation, J Comp Physiol Psychol, 60, 158, 10.1037/h0022365 Routtenberg, 1972, Self-stimulation in the frontal cortex of Rattus norvegicus, Behav Biol, 7, 567, 10.1016/S0091-6773(72)80218-9 Rowlett, 2000, A labor-supply analysis of cocaine self-administration under progressive-ratio schedules: antecedents, methodologies, and perspectives, Psychopharmacology, 153, 1, 10.1007/s002130000610 Sachs, 1975, Mechanisms of action of 6-hydroxydopamine, Biochem Pharmacol, 24, 1, 10.1016/0006-2952(75)90304-4 Saigusa, 1999, High and low responders to novelty: effects of a catecholamine synthesis inhibitor on novelty induced changes in behavior and release of accumbal dopamine, Neuroscience, 88, 1153, 10.1016/S0306-4522(98)00275-9 Sanchez, 2001, Conditioned fear stimuli reinstate cocaine-induced conditioned place preference, Brain Res, 908, 86, 10.1016/S0006-8993(01)02638-5 Saul'skaya, 1990, The role of the hippocampal formation in controlling GABA release in the nucleus accumbens during an emotional conditioned response, Neurosci Behav Physiol, 29, 461, 10.1007/BF02461086 Schiefer, 2001, Evaluation of extensive visual field defects with computer-assisted kinetic perimetry, Klin Monatsbl Augenheilkd, 218, 13, 10.1055/s-2001-11255 Schiffer, 2000, Stereoselective inhibition of dopaminergic activity by gamma vinyl-GABA following a nicotine or cocaine challenge: a PET/microdialysis study, Life Sci [Pharmacol Lett], 66, PL169, 10.1016/S0024-3205(00)00432-X Schiffer, 2003, Sub-chronic low dose gamma-vinyl GABA (vigabatrin) inhibits cocaine-induced increases in nucleus accumbens dopamine, Psychopharmacology, 168, 339, 10.1007/s00213-003-1446-6 Seeger, 1981, Amphetamine and morphine: additive effects on ICSS threshold, Soc Neurosci Abstr, 7, 974 Seeger, 1979, Enhancement of self-stimulation behavior in rats and monkeys after chronic neuroleptic treatment: evidence for mesolimbic supersensitivity, Brain Res, 175, 49, 10.1016/0006-8993(79)90513-4 Self, 1998, Neural substrates of drug craving and relapse in drug addiction, Ann Med, 30, 379, 10.3109/07853899809029938 Self, 1995, Molecular mechanisms of drug reinforcement and addiction, Annu Rev Neurosci, 18, 463, 10.1146/annurev.ne.18.030195.002335 Self, 1998, Relapse to drug-seeking: neural and molecular mechanisms, Drug Alcohol Depend, 51, 49, 10.1016/S0376-8716(98)00065-9 Self, 1996, Opposite modulation of cocaine-seeking behavior by D1- and D2-like dopamine receptor agonists, Science, 271, 1586, 10.1126/science.271.5255.1586 Senoh, 1959, Chemical, enzymatic, and metabolic studies on the mechanism of oxidation of dopamine, J Am Chem Soc, 81, 6236, 10.1021/ja01532a030 Sesack, 1992, Prefrontal cortical efferents in the rat synapse on unlabelled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area, J Comp Neurol, 320, 145, 10.1002/cne.903200202 Sesack, 1995, Ultrastructural relationships between terminals immunoreactive for enkephalin, GABA, or both transmitters in the rat ventral tegmental area, Brain Res, 672, 261, 10.1016/0006-8993(94)01391-T Shaham, 1993, Immobilization stress-induced oral opioid self-administration and withdrawal in rats: role of conditioning factors and the effect of stress on ‘relapse’ to opioid drugs, Psychopharmacology, 111, 477, 10.1007/BF02253539 Shaham, 1995, Stress reinstates heroin-seeking in drug-free animals: an effect mimicking heroin, not withdrawal, Psychopharmacology, 119, 334, 10.1007/BF02246300 Shaham, 1996, Effects of opioid and dopamine receptor antagonists on relapse induced by stress and re-exposure to heroin in rats, Psychopharmacology, 125, 385, 10.1007/BF02246022 Shaham, 1996, Relapse to heroin-seeking under opioid maintenance: the effects of stress, heroin-priming, and withdrawal, J Neurosci, 16, 1957, 10.1523/JNEUROSCI.16-05-01957.1996 Shaham, 1997, Corticotropin-releasing factor, but not corticosterone, is involved in stress-induced relapse to heroin-seeking in rats, J Neurosci, 17, 2605, 10.1523/JNEUROSCI.17-07-02605.1997 Shaham, 1998, CP-154,526, a selective, non-peptide antagonist of the corticotropin-releasing factor1 receptor attenuates stress-induced relapse to drug-seeking in cocaine- and heroin-trained rats, Psychopharmacology, 137, 184, 10.1007/s002130050608 Shaham, 2000, Stress-induced relapse to heroin and cocaine seeking in rats: a review, Brain Res Rev, 33, 13, 10.1016/S0165-0173(00)00024-2 Shaham, 2000, Clonidine blocks stress-induced reinstatement of heroin seeking in rats: an effect independent of locus coeruleus noradrenergic neurons, Eur J Neurosci, 12, 292, 10.1046/j.1460-9568.2000.00899.x Shaham, 2003, The reinstatement model of drug relapse: history, methodology and major findings, Psychopharmacology, 168, 3, 10.1007/s00213-002-1224-x Shalev, 2000, Stress and relapse to drug seeking in rats: studies on the generality of the effect, Psychopharmacology, 150, 337, 10.1007/s002130000441 Shalev, 2002, Neurobiology of relapse to heroin and cocaine seeking: a review, Pharmacol Rev, 54, 1, 10.1124/pr.54.1.1 Shalev, 2003, The role of corticosterone in food deprivation-induced reinstatement of cocaine seeking in the rat, Psychopharmacology, 168, 170, 10.1007/s00213-002-1200-5 Shiffman, 1982, Relapse following smoking cessation: a situational analysis, J Consult Clin Psychol, 50, 71, 10.1037/0022-006X.50.1.71 Shiffman, 1996, First lapses to smoking: within-subjects analysis of real-time reports, J Consult Clin Psychol, 64, 366, 10.1037/0022-006X.64.2.366 Shizgal, 1980, Behavioral methods for inferring anatomical linkage between rewarding brain stimulation sites, J Comp Physiol Psychol, 94, 227, 10.1037/h0077668 Shoaib, 1998, The GABAB agonist baclofen modifies cocaine self-administration in rats, Behav Pharmacol, 9, 195 Shoptaw, 2003, Randomized placebo-controlled trial of baclofen for cocaine dependence: preliminary effects for individuals with chronic patterns of cocaine use, J Clin Psychiatry, 64, 1440, 10.4088/JCP.v64n1207 Shuster, 1977, Sensitization to cocaine stimulation in mice, Psychopharmacology, 52, 185, 10.1007/BF00439108 Siegel, 1976, Morphine analgesic tolerance: its situation specificity supports a Pavlovian conditioning model, Science, 193, 323, 10.1126/science.935870 1992, vol. 116, 213 Siegel, 1982, Heroin “overdose” death: contribution of drug-associated environmental cues, Science, 216, 436, 10.1126/science.7200260 Silverman, 1992, Low-dose caffeine discrimination and self-reported mood effects in normal volunteers, J Exp Anal Behav, 57, 91, 10.1901/jeab.1992.57-91 Sinha, 1999, Stress-induced craving and stress responses in cocaine dependent individuals, Psychopharmacology, 142, 343, 10.1007/s002130050898 Slattery, 2005, The GABAB receptor-positive modulator GS39783 and the GABAB receptor agonist baclofen attenuate the reward-facilitating effects of cocaine: intracranial self-stimulation studies in the rat, J Clin Psychiatry, 64, 1440 Smith, 1962, Subjective effects of heroin and morphine in normal subjects, J Pharmacol Exp Ther, 136, 47 Smith, 2004, Effects of positive allosteric modulators of the GABAB receptor on cocaine self-administration in rats, Psychopharmacology, 173, 105, 10.1007/s00213-003-1706-5 Sofuoglu, 2005, Novel approaches to the treatment of cocaine addiction, CNS Drugs, 19, 13, 10.2165/00023210-200519010-00002 Sokoloff, 1990, Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics, Nature, 347, 146, 10.1038/347146a0 Sokoloff, 1992, The third dopamine receptor (D3) as a novel target for antipsychotics, Biochem Pharmacol, 43, 659, 10.1016/0006-2952(92)90227-A Spyraki, 1983, Attenuation of heroin reward in rats by disruption of the mesolimbic dopamine system, Psychopharmacology, 79, 278, 10.1007/BF00427827 Spyraki, 1987, Intravenous cocaine-induced place preference: attenuation by haloperidol, Behav Brain Res, 26, 57, 10.1016/0166-4328(87)90016-7 Stafford, 1998, Progressive-ratio schedules of drug delivery in the analysis of drug self-administration: a review, Psychopharmacology, 139, 169, 10.1007/s002130050702 Staley, 1996, Adaptive increase in D3 dopamine receptors in the brain reward circuits of human cocaine fatalities, J Neurosci, 16, 6100, 10.1523/JNEUROSCI.16-19-06100.1996 Stein, 1962, Effects and interactions of imipramine, chlorpromazine, reserpine, and amphetamine on self-stimulation: possible neurophysiological basis of depression, Recent Adv Biol Psychiatry, 4, 297 Stein, 1977, Direct intracerebral self-administration of opiates in the rat, Soc Neurosci Abstr, 3, 302 Stein, 1960, Brain stimulation reward ‘thresholds’ self-determined in rat, Psychopharmacologia, 1, 251, 10.1007/BF00402746 Stemp, 2000, Design and synthesis of trans-N-[4-[2-(6-cyano-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl]cyclohexyl]-4-quinolinecarboxamide (SB-277011): a potent and selective dopamine D3 receptor antagonist with high oral bioavailability and CNS penetration in the rat, J Med Chem, 43, 1878, 10.1021/jm000090i Stewart, 1984, Reinstatement of heroin and cocaine self-administration in the rat by intracerebral application of morphine in the ventral tegmental area, Pharmacol Biochem Behav, 20, 917, 10.1016/0091-3057(84)90017-0 Stewart, 1988, A comparison of the effect of intra-accumbens injections of amphetamine and morphine on reinstatement of heroin intravenous self-administration behavior, Brain Res, 457, 287, 10.1016/0006-8993(88)90698-1 Stewart, 1992, Reinstatement of heroin self-administration habits: morphine prompts and naltrexone discourages renewed responding after extinction, Psychopharmacology, 108, 79, 10.1007/BF02245289 Stretch, 1971, Factors affecting behavior maintained by response-contingent intravenous infusions of amphetamine in squirrel monkeys, Can J Physiol Pharmacol, 49, 581, 10.1139/y71-075 Stromberg, 2004, The effect of baclofen alone and in combination with naltrexone on ethanol consumption in the rat, Pharmacol Biochem Behav, 78, 743, 10.1016/j.pbb.2004.05.006 Stromberg, 2001, The effect of gamma-vinyl-GABA on the consumption of concurrently available oral cocaine and ethanol in the rat, Pharmacol Biochem Behav, 68, 291, 10.1016/S0091-3057(00)00456-1 Sundstrom, 2002, Effects of isolation-rearing on intracranial self-stimulation reward of the lateral hypothalamus: baseline assessment and drug challenges, Life Sci, 70, 2799, 10.1016/S0024-3205(02)01509-6 Sutton, 2000, Factors that determine a propensity for cocaine-seeking behavior during abstinence in rats, Neuropsychopharmacology, 22, 626, 10.1016/S0893-133X(99)00160-8 Taepavarapruk, 2003, Neurochemical correlates of relapse to d-amphetamine self-administration by rats induced by stimulation of the ventral subiculum, Psychopharmacology, 168, 99, 10.1007/s00213-002-1337-2 Ternes, 1984, Nondependent monkeys self-administer hydromorphone, Behav Neurosci, 99, 583, 10.1037/0735-7044.99.3.583 Thanos, 2005, The selective dopamine D3 receptor antagonist SB-277011-A attenuates ethanol consumption in ethanol preferring (P) and non-preferring (NP) rats, Pharmacol Biochem Behav, 81, 190, 10.1016/j.pbb.2005.03.013 Thompson, 1964, Morphine self-administration, food-reinforced and avoidance behaviors in rhesus monkeys, Psychopharmacologia, 5, 87, 10.1007/BF00413045 Tran-Nguyen, 1998, Time-dependent changes in cocaine-seeking behavior and dopamine overflow in the amygdala during cocaine withdrawal, Neuropsychopharmacology, 19, 48, 10.1016/S0893-133X(97)00205-4 Tzschentke, 1998, Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues, Prog Neurobiol, 56, 613, 10.1016/S0301-0082(98)00060-4 Ungerstedt, 1968, 6-Hydroxy-dopamine-induced degeneration of central dopamine neurons, Eur J Pharmacol, 5, 107, 10.1016/0014-2999(68)90164-7 Ungerstedt, 1984, Measurement of neurotransmitter release by intracranial dialysis, vol. 6, 81 Ungerstedt, 1974, Functional correlates of dopamine neurotransmission, Bull Schweiz Akad Med Wiss, 30, 44 Uzwiak, 1997, Neurons in accumbens subterritories of the rat: phasic firing time-locked within seconds of intravenous cocaine self-infusion, Brain Res, 767, 363, 10.1016/S0006-8993(97)00752-X Valverde, 1996, Protein kinases in the rat nucleus accumbens are involved in the aversive component of opiate withdrawal, Eur J Neurosci, 8, 2671, 10.1111/j.1460-9568.1996.tb01562.x Van Putten, 1978, Akinetic depression in schizophrenia, Arch Gen Psychiatry, 35, 1101, 10.1001/archpsyc.1978.01770330075006 Van Putten, 1981, Subjective response to antipsychotic drugs, Arch Gen Psychiatry, 38, 187, 10.1001/archpsyc.1981.01780270073010 van Ree, 1980, Involvement of neurohypophyseal peptides in drug-mediated adaptive responses, Pharmacol Biochem Behav, 13, 1101 Vetulani, 2001, Drug addiction: Part III. Pharmacotherapy of addiction, Pol J Pharmacol, 53, 415 Vezina, 2004, Sensitization of midbrain dopamine neuron activity and the self-administration of psychomotor stimulant drugs, Neurosci Biobehav Rev, 27, 827, 10.1016/j.neubiorev.2003.11.001 Volkow, 2004, Drug addiction: the neurobiology of behavior gone awry, Nat Rev Neurosci, 5, 963, 10.1038/nrn1539 Volkow, 1999, Reinforcing effects of psychostimulants in humans are associated with increases in brain dopamine and occupancy of D(2) receptors, J Pharmacol Exp Ther, 291, 409 Volpicelli, 1990, Naltrexone and the treatment of alcohol dependence: initial observations, 195 Volpicelli, 1992, Naltrexone in the treatment of alcohol dependence, Arch Gen Psychiatry, 49, 876, 10.1001/archpsyc.1992.01820110040006 Vorel, 2001, Drug addiction and the hippocampus, Science, 294, 1235a, 10.1126/science.294.5545.1235a Vorel, 2001, Relapse to cocaine-seeking after hippocampal theta burst stimulation, Science, 292, 1175, 10.1126/science.1058043 Vorel, 2002, Dopamine D3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in rats, J Neurosci, 22, 9595, 10.1523/JNEUROSCI.22-21-09595.2002 Voruganti, 1997, Neuroleptic dysphoria may be the missing link between schizophrenia and substance abuse, J Nerv Ment Dis, 185, 463, 10.1097/00005053-199707000-00008 Voruganti, 2000, Comparative evaluation of conventional and novel antipsychotic drugs with reference to their subjective tolerability, side-effect profile and impact on quality of life, Schizophr Res, 43, 135, 10.1016/S0920-9964(99)00154-1 Walker, 2002, Conditioned opioid withdrawal decreases nociceptin/orphanin FQ levels in the frontal cortex and olfactory tubercle, Neuropsychopharmacology, 27, 203, 10.1016/S0893-133X(02)00292-0 Wang, 2000, Stress or drug priming induces reinstatement of extinguished conditioned place preference, NeuroReport, 11, 2781, 10.1097/00001756-200008210-00034 Warburton, 1996, Calcium dependent dopamine release in rat nucleus accumbens following amphetamine challenge: implications for the disruption of latent inhibition, Behav Pharmacol, 7, 119, 10.1097/00008877-199603000-00002 Ward, 1997, The effects of a monetary alternative on marijuana self-administration, Behav Pharmacol, 8, 275, 10.1097/00008877-199708000-00001 Ward, 2000, Intraaccumbens baclofen selectively enhances feeding behavior in the rat, Physiol Behav, 68, 463, 10.1016/S0031-9384(99)00197-3 Weeks, 1964, Factors affecting voluntary morphine intake in self-maintained addicted rats, Psychopharmacologia, 6, 267, 10.1007/BF00413156 Wegelius, 1993, Gamma-vinyl GABA decreases voluntary alcohol-consumption in alcohol-preferring AA rats, Pharmacol Toxicol, 73, 150, 10.1111/j.1600-0773.1993.tb01554.x Weiss, 1993, Oral alcohol self-administration stimulates dopamine release in the rat nucleus accumbens: genetic and motivational determinants, J Pharmacol Exp Ther, 267, 250 Weiss, 2000, Control of cocaine-seeking behavior by drug-associated stimuli in rats: effects on recovery of extinguished operant-responding and extracellular dopamine levels in amygdala and nucleus accumbens, Proc Natl Acad Sci U S A, 97, 4321, 10.1073/pnas.97.8.4321 Weissman, 1989, Opioid pseudoaddiction—an iatrogenic syndrome, Pain, 36, 363, 10.1016/0304-3959(89)90097-3 White, 1993, Amphetamine-conditioned cue preference and the neurobiology of drug-seeking, Semin Neurosci, 5, 329, 10.1016/S1044-5765(05)80040-5 Whitelaw, 1996, Excitotoxic lesions of the basolateral amygdala impair the acquisition of cocaine-seeking behaviour under a second order schedule of reinforcement, Psychopharmacology, 127, 213, 10.1007/BF02805996 Wikler, 1948, Recent progress in research on the neurophysiological basis of morphine addiction, Am J Psychiatry, 105, 329, 10.1176/ajp.105.5.329 Wikler, 1968, Interaction of physical dependence and classical and operant conditioning in the genesis of relapse, 280 Wikler, 1967, Classical conditioning of a morphine abstinence phenomenon, reinforcement of opioid-drinking behavior and relapse in morphine-addicted rats, Psychopharmacologia, 10, 255, 10.1007/BF00401386 Wilson, 1995, Dopaminergic correlates of motivated behavior: importance of drive, J Neurosci, 15, 5169, 10.1523/JNEUROSCI.15-07-05169.1995 Wise, 1980, The dopamine synapse and the notion of ‘pleasure centers’ in the brain, Trends Neurosci, 3, 91, 10.1016/0166-2236(80)90035-1 Wise, 1980, Action of drugs of abuse on brain reward systems, Pharmacol Biochem Behav, 13, 213, 10.1016/S0091-3057(80)80033-5 Wise, 1981, Brain dopamine and reward, vol. 1, 103 Wise, 1982, Neuroleptics and operant behavior: the anhedonia hypothesis, Behav Brain Sci, 5, 39, 10.1017/S0140525X00010372 Wise, 1984, Neural mechanisms of the reinforcing action of cocaine, NIDA Res Monogr, 50, 15 Wise, 1989, The brain and reward, 377 Wise, 1989, Opiate reward: sites and substrates, Neurosci Biobehav Rev, 13, 129, 10.1016/S0149-7634(89)80021-1 Wise, 1993, In vivo estimates of extracellular dopamine and dopamine metabolite levels during intravenous cocaine or heroin self-administration, Sem Neurosci, 5, 337, 10.1016/S1044-5765(05)80041-7 Wise, 1996, Addictive drugs and brain stimulation reward, Annu Rev Neurosci, 19, 319, 10.1146/annurev.ne.19.030196.001535 Wise, 1996, Neurobiology of addiction, Curr Opin Neurobiol, 6, 129, 10.1016/S0959-4388(96)80079-1 Wise, 1998, Drug-activation of brain reward pathways, Drug Alcohol Depend, 51, 13, 10.1016/S0376-8716(98)00063-5 Wise, 2004, Dopamine, learning and motivation, Nat Rev Neurosci, 5, 1, 10.1038/nrn1406 Wise, 1981, Brain substrates for reinforcement and drug self-administration, Prog Neuropsychopharmacol, 5, 467, 10.1016/0364-7722(81)90028-X Wise, 1984, Brain reward circuitry: four circuit elements ‘wired’ in apparent series, Brain Res Bull, 12, 203, 10.1016/0361-9230(84)90190-4 Wise, 2002, Functional anatomy of substance-related disorders, 509 Wise, 1989, Brain dopamine and reward, Annu Rev Psychol, 40, 191, 10.1146/annurev.ps.40.020189.001203 Wise, 1990, Bromocriptine self-administration and bromocriptine-reinstatement of cocaine-trained and heroin-trained lever pressing in rats, Psychopharmacology, 100, 355, 10.1007/BF02244606 Wise, 1995, Fluctuations in nucleus accumbens dopamine concentration during intravenous cocaine self-administration in rats, Psychopharmacology, 120, 10, 10.1007/BF02246140 Wise, 1995, Elevations of nucleus accumbens dopamine and DOPAC levels during intravenous heroin self-administration, Synapse, 21, 140, 10.1002/syn.890210207 Woolverton, 1986, Effects of a D1 and D2 dopamine antagonist on the self-administration of cocaine and piribedil by rhesus monkeys, Pharmacol Biochem Behav, 24, 531, 10.1016/0091-3057(86)90553-8 Xi, 1999, Baclofen inhibits heroin self-administration behavior and mesolimbic dopamine release, J Pharmacol Exp Ther, 290, 1369 Xi, 2000, Increased mesolimbic GABA concentration blocks heroin self-administration in the rat, J Pharmacol Exp Ther, 294, 613 Xi, 2003, The dopamine D3 receptor antagonist NGB 2904 inhibits cocaine reward and cocaine-triggered reinstatement of cocaine-seeking behavior Xi, 2004, Blockade of mesolimbic dopamine D3 receptors inhibits stress-induced reinstatement of cocaine-seeking in rats, Psychopharmacology, 176, 57, 10.1007/s00213-004-1858-y Xi, 2005, Selective dopamine D3 receptor antagonism by SB-277011A attenuates cocaine reinforcement as assessed by progressive-ratio and variable-cost-variable-payoff fixed-ratio cocaine self-administration in rats, Eur J Neurosci, 21, 3427, 10.1111/j.1460-9568.2005.04159.x Yan, 1999, Focal bicuculline increases extracellular dopamine concentration in the nucleus accumbens of freely moving rats as measured by in vivo microdialysis, Eur J Pharmacol, 385, 7, 10.1016/S0014-2999(99)00699-8 Yokel, 1975, Increased lever pressing for amphetamine after pimozide in rats: implications for a dopamine theory of reward, Science, 187, 547, 10.1126/science.1114313 Yokel, 1976, Attenuation of intravenous amphetamine reinforcement by central dopamine blockade in rats, Psychopharmacology, 48, 311, 10.1007/BF00496868 Young, 1998, Increased extracellular dopamine in the nucleus accumbens of the rat during associative learning of neutral stimuli, Neuroscience, 83, 1175, 10.1016/S0306-4522(97)00483-1 Yuan, 1998, NGB 2904 and NGB 2849: two highly selective dopamine D3 receptor antagonists, Bioorg Med Chem Lett, 8, 2715, 10.1016/S0960-894X(98)00469-7 Zangen, 2002, Rewarding and psychomotor stimulant effects of endomorphin-1: anteroposterior differences within the ventral tegmental area and lack of effect in nucleus accumbens, J Neurosci, 22, 7225, 10.1523/JNEUROSCI.22-16-07225.2002